David Jones
Ensuring CRO Accountability in Clinical Research, Interview with Paula Arranz Gutiérrez
Ensuring CRO Accountability in Clinical Research I recently had the opportunity to interview Paula Arranz Gutiérrez, an experienced...
top of page
Blog
Search
David Jones
- 5 min
Clinical Trial Randomization: Handle with Care – One Chance, No Regrets, Interview with IDDI
Randomization in clinical trials ensures unbiased assignment of participants to treatment groups. It minimizes confounding variables and...
David Jones
- 3 min
Partnerships in Clinical Research, Interview with Joan Chambers
Collaboration with non-profit organizations plays a major role in clinical research, and to learn more, I sat down with Joan Chambers to...
David Jones
- 3 min
8 Top Tips for Maximising Event Participation, Interview with Joan Chambers
Industry conferences in the clinical research space widely benefit attendees, accelerate industry-wide innovation, as well as enabling...
David Jones
- 3 min
How do European Regulatory Policies Support Biotech Investment?, Interview with Sam Vakili
In continuation of our series of interviews, Sam Vakili, Founder & CEO, INVEST.IN.TEK shared with me his views on the impact of European...
David Jones
- 3 min
Current Trends in Biotech Investments in Europe, Interview with Sam Vakili
In continuation of our series of interviews, Sam Vakili, Founder & CEO, INVEST.IN.TEK shared with me his opinion on the current trends...
David Jones
- 3 min
Challenges Faced at Study Site Level, Interview with Philipp Badorrek
Since the pandemic there is an increasing number of clinical trials being initiated, outpacing the capacity of available study sites. In...
David Jones
- 4 min
Bulgaria Opportunity for Clinical Research, Interview with Dana Leff Niedzielska
In January 2022 the European Medicines Agency (EMA) introduced the new Clinical Trials Information System (CTIS). Alongside new Clinical...
David Jones
- 3 min
Financial Oversight in Clinical Studies, Interview with Helen Blanco
Maintaining sufficient financial oversight in clinical studies will present several challenges, I sat down with Helen Blanco, Vice...
bottom of page